variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
CBS-I278T,CBS,This recessive mutation causes homocystinuria in a recessive manner and is found in patients responsive to pyridoxine treatment.,High,Likely,Pathogenic,0.0029,Genital and urinary;Metabolism,Recessive,Heterozygous,7611293;8554066;8940271;9813456;15972722;19683694,rs5742905,5,chr21,44483184,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
RPGRIP1-D1114G,RPGRIP1,"This variant is hypothesized to cause Leber's Congenital Amaurosis in a recessive manner (causing severe vision loss and blindness), but stastical significance cannot be established without any observations of allele frequency in controls. This variant is a missense and predicted by Polyphen 2 to have a benign effect, while other causal variants implicated in this gene are severe truncating variants (nonsense or frameshift mutations).",High,Uncertain,Pathogenic,0.026,Hearing and vision,Recessive,Heterozygous,11528500,rs17103671,5,chr14,21811196,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
ABCA4-V2050L,ABCA4,Reported to cause Stargardt Disease (progressive vision loss) in a recessive manner.,High,Uncertain,Pathogenic,0.0037,Hearing and vision,Recessive,Heterozygous,9054934;9288113,rs41292677,5,chr1,94467548,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
LPL-N318S,LPL,"Also called N291S, this variant has been associated with high hypertriglyceridemia. According to data from Wright et al., carriers of this variant may be two to three times more likely to have very high triglyceride levels, although it is unknown what effect this may have on coronary heart disease.",Moderate,Uncertain,Pathogenic,0.013,Heart and circulatory;Metabolism,Dominant,Heterozygous,18068174,rs268,3,chr8,19813529,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
SERPINA1-E288V,SERPINA1,"This variant represents the PiS variant in alpha-1-antitrypsin deficiency where a homozygous individual has 60% enzymatic activity. This variant alone is unlikely to much effect, but 3-4% of heterozygotes are compound heterozygous with the more severe PiZ variant, which is associated with an increased risk of emphysema and COPD.",Low,Well-established,Pathogenic,0.03,"Breathing;Metabolism;Mouth, liver, and digestive",Recessive,Heterozygous,6093867;8970361;10194472;15711957;16608528;18565211;19956452,rs17580,1,chr14,94847262,A,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
LRP5-A1330V,LRP5,"In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.

 
",Low,Uncertain,Pathogenic,0.11,"Muscular, skeletal, and connective tissue",Complex/Other,Heterozygous,18455228;19148563;20953208,rs3736228,2,chr11,68201295,T,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Heterozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Homozygous,,rs1544410,0,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Homozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
TOR1A-D216H,TOR1A,This SNP has been shown to be benign and play a protective role against Dystonia.  ,Low,Likely,Protective,0.1,Nervous system,Unknown,Heterozygous,18519876;19380705;20669276,rs1801968,1,chr9,132580901,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Homozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
MC4R-V103I,MC4R,"This variant was associated with a reduced incidence of obesity in a large meta-analysis of more than 55,000 individuals. ",Low,Uncertain,Protective,0.016,Metabolism,Unknown,Heterozygous,19696756,rs2229616,,chr18,58039276,T,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
PKD1-A4059V,PKD1,Probably benign.,Low,Likely,Benign,0.057,Other,Unknown,Heterozygous,19686598,rs3209986,,chr16,2140554,A,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
FLT4-N149D,FLT4,"Other severe variants in this gene are implicated in causing Milroy Disease (primary lymphedema) in a recessive manner. Although this variant is rare (2.3% allele frequency), it is still common enough that it is highly unlikely to have a severe, high penetrance pathogenic effect.",Low,Likely,Benign,0.073,Blood,Unknown,Heterozygous,11292664,rs34221241,,chr5,180057293,C,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
COL5A2-P460S,COL5A2,"Tentatively benign. Although predicted to be damaging by Polyphen 2, this variant is seen in 2 out of 62 PGP & public genomes. OMIM lists other more disruptive variants (frameshift & nonsense) as reported to cause Ehlers-Danlos syndrome when homozygous.",Low,Uncertain,Benign,0.04,"Muscular, skeletal, and connective tissue",Unknown,Heterozygous,,rs35830636,,chr2,189932764,A,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
MLH3-E624Q,MLH3,"Probably benign, follow-up studies have failed to support any link with colorectal cancer and the protein function is identical to wildtype.",Low,Uncertain,Benign,0.0082,Cancer,Unknown,Heterozygous,11586295;12702580;19156873,rs28756986,,chr14,75514489,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
GALT-N314D,GALT,"This variant has an allele frequency of ~8% and is ancestral to ""Duarte"" / ""Duarte 2"" and ""Duarte 1""/""Los Angeles"" galactosemia variants. This variant is evolutionarily ancestral, and in vitro studies fail to support an impact of this variant on enzyme activity. Carney et al. instead implicate a 4 base deletion on the 5' of the GALT gene as being causal and linked to this variant. Galactosemia is typically screened and detected in infants and causes early, severe but nonspecific symptoms (digestive problems, lethargy, failure to thrive).",Low,Uncertain,Benign,0.072,"Mouth, liver, and digestive",Unknown,Heterozygous,10408771;11261429;19224951,rs2070074,,chr9,34649442,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
PTCH1-P1315L,PTCH1,"Common polymorphism, presumed benign.",Low,Uncertain,Benign,0.3,Other,Unknown,Heterozygous,15712338,rs357564,,chr9,98209594,A,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
NTRK1-G613V,NTRK1,"Also called G607V, this variant has been reported as a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.043,Other,Unknown,Heterozygous,10330344;10443680;11159935,rs6339,,chr1,156848946,T,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
NTRK1-H604Y,NTRK1,"Various databases and papers treat this variant as a non-pathogenic polymorphism, although it is fairly uncommon and is computational methods predict it to be damaging.",Low,Uncertain,Benign,0.043,Other,Unknown,Heterozygous,10443680;16412461;21228398,rs6336,,chr1,156848918,T,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
GUCY2D-A52S,GUCY2D,"One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.",Low,Uncertain,Benign,0.21,Hearing and vision,Recessive,Heterozygous,8944027,rs61749665,,chr17,7906519,T,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
RAPSN-R58C,RAPSN,Reported as non-pathogenic polymorphism. ,Low,Uncertain,Benign,0.078,Other,Unknown,Heterozygous,11791205,rs34312154,,chr11,47470345,A,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=8a3a0838a3204263895f6a0f0a0e62e79cd46a12&access_token=e017a65d39b94dfad658f7c1f97a0b50
